SSI Diagnostica A/S

CVR: 37294535

Growing 28% p.a.Medium companyWell-established (10 yrs)Loss-making

Secondary names: SSI Diagnostica Group A/S

Active

The financial health of SSI Diagnostica A/S appears to be under pressure, with a significant decline in profitability over the past two years. In 2024, the company reported revenues of 238.3 million DKK but incurred a loss of 57.7 million DKK, following a loss of 126.8 million DKK in 2023. Despite these challenges, equity has remained relatively stable, increasing to 1.27 billion DKK in 2024, indicating a strong capital base. However, the sharp drop in revenue from 316.1 million DKK in 2022 to the current levels raises concerns about its market position and operational efficiency within the pharmaceutical manufacturing sector.

AI-generated summary

Overview

Company type: A/S; Aktieselskab
Address: Herredsvejen 2, 3400 Hillerød; HILLERØD; 3400 Hillerød; Find nearby companies
Founded: 11.12.2015

Details

Industry: Fremstilling af farmaceutiske præparater; Code: 212000
Secondary industries: Fremstilling af andre kemiske produkter i.a.n. (205900); Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Employees: 108 employees; 103 FTE; (2018)
Capital: 1.765.000 kr.

Purpose

Selskabets formål er at drive virksomhed med udvikling, produktion og salg af in vitro diagnostika til mikrobiologisk diagnostik og kontrol samt hygiejnemonitorering i indland og udland, samt anden dermed beslægtet virksomhed.